|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of NovoCure (NASDAQ: NVCR) through any online brokerage.
The latest price target for NovoCure (NASDAQ: NVCR) was reported by Truist Securities on 2021-04-19. The analyst firm set a price target for 142.00 expecting NVCR to fall to within 12 months (a possible -26.21% downside). 9 analyst firms have reported ratings in the last year.
The stock price for NovoCure (NASDAQ: NVCR) is $192.45 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for NovoCure.
There is no upcoming split for NovoCure.